IT202200006119A1 - Method for implementing the design of synthetic nucleic acid molecules for gene therapies in rare diseases. - Google Patents

Method for implementing the design of synthetic nucleic acid molecules for gene therapies in rare diseases. Download PDF

Info

Publication number
IT202200006119A1
IT202200006119A1 IT102022000006119A IT202200006119A IT202200006119A1 IT 202200006119 A1 IT202200006119 A1 IT 202200006119A1 IT 102022000006119 A IT102022000006119 A IT 102022000006119A IT 202200006119 A IT202200006119 A IT 202200006119A IT 202200006119 A1 IT202200006119 A1 IT 202200006119A1
Authority
IT
Italy
Prior art keywords
implementing
design
nucleic acid
acid molecules
synthetic nucleic
Prior art date
Application number
IT102022000006119A
Other languages
English (en)
Inventor
Alessandra Ferlini
Rachele Rossi
Original Assignee
Univ Degli Studi Di Ferrara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Ferrara filed Critical Univ Degli Studi Di Ferrara
Priority to IT102022000006119A priority Critical patent/IT202200006119A1/it
Publication of IT202200006119A1 publication Critical patent/IT202200006119A1/it

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
IT102022000006119A 2022-03-29 2022-03-29 Method for implementing the design of synthetic nucleic acid molecules for gene therapies in rare diseases. IT202200006119A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102022000006119A IT202200006119A1 (it) 2022-03-29 2022-03-29 Method for implementing the design of synthetic nucleic acid molecules for gene therapies in rare diseases.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000006119A IT202200006119A1 (it) 2022-03-29 2022-03-29 Method for implementing the design of synthetic nucleic acid molecules for gene therapies in rare diseases.

Publications (1)

Publication Number Publication Date
IT202200006119A1 true IT202200006119A1 (it) 2023-09-29

Family

ID=82019382

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000006119A IT202200006119A1 (it) 2022-03-29 2022-03-29 Method for implementing the design of synthetic nucleic acid molecules for gene therapies in rare diseases.

Country Status (1)

Country Link
IT (1) IT202200006119A1 (it)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170368198A1 (en) * 2016-06-21 2017-12-28 The University Of North Carolina At Chapel Hill Optimized mini-dystrophin genes and expression cassettes and their use
WO2021226461A1 (en) * 2020-05-07 2021-11-11 Translate Bio, Inc. Generation of optimized nucleotide sequences

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170368198A1 (en) * 2016-06-21 2017-12-28 The University Of North Carolina At Chapel Hill Optimized mini-dystrophin genes and expression cassettes and their use
WO2021226461A1 (en) * 2020-05-07 2021-11-11 Translate Bio, Inc. Generation of optimized nucleotide sequences

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BIRKHOLTZ ET AL., MALARIA J, vol. 7, 2008, pages 197 - 217
FANG M ET AL: "O.11Dystrophin gene codon usage lacks extreme codon bias and shows non-random codon distribution of disease-causing mutations", NEUROMUSCULAR DISORDERS, ELSEVIER LTD, GB, vol. 29, 29 September 2019 (2019-09-29), XP085844575, ISSN: 0960-8966, [retrieved on 20190929], DOI: 10.1016/J.NMD.2019.06.029 *
GOULD N ET AL: "Computational tools and algorithms for designing customized synthetic genes", FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, FRONTIERS RESEARCH FOUNDATION, CH, vol. 2, 6 October 2014 (2014-10-06), pages 41 - 1, XP002755946, ISSN: 2296-4185, [retrieved on 20140101], DOI: 10.3389/FBIOE.2014.00041 *
NAKAMURA ET AL., NUCLEIC ACIDS RES., vol. 28, 2000, pages 292
ROSSI RACHELE ET AL: "Calculating and comparing codon usage values in rare disease genes highlights codon clustering with disease-and tissue- specific hierarchy", PLOS ONE, vol. 17, no. 3, 31 March 2022 (2022-03-31), pages e0265469, XP055982992, DOI: 10.1371/journal.pone.0265469 *
SHARPLI, NUCLEIC ACIDS RES., vol. 15, 1987, pages 1281 - 95
WEISSBACH H: "Years of Molecular Biology", vol. 736, 2012, ELSEVIER, article "Syntax of referencing in Molecular Mechanisms of Protein Biosynthesis", pages: 3 - 5

Similar Documents

Publication Publication Date Title
EA201991262A1 (ru) Библиотеки вариантов иммунологического синапса и их синтез
EA201890763A1 (ru) Библиотеки вариантных олигонуклеиновых кислот и их синтез
SG10201906673WA (en) Artificial nucleic acid molecules
Almamun et al. Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia
EP4322168A3 (en) Methods for fragmentome profiling of cell-free nucleic acids
FI3604532T3 (fi) Uusia crispr-entsyymejä ja järjestelmiä
IL280652A (en) Nucleic acid molecules and their use for non-viral gene therapy
BR122021025194A8 (pt) Molécula de ácido nucleico, método para obter rna, rna, método para obter um peptídeo ou proteína e usos in vitro ou ex vivo do rna
WO2019135816A3 (en) Novel nucleic acid modifiers
EP4328322A3 (en) Probe library construction
EP4406585A3 (en) Nucleic acid products and methods of administration thereof
BR122022007092B8 (pt) Método para construir um perfil de dna, método para construir uma biblioteca de ácido nucléico, biblioteca de ácido nucléico, pluralidade de iniciadores e kit
BR112015012375A2 (pt) modificação e regulação de genoma à base de crispr
WO2020198509A3 (en) Modified oligonucleotides with increased stability
EA201690529A1 (ru) Способы модификации клетки-хозяина
Sarkar et al. MicroRNAs and the genetic nexus of brain aging, neuroinflammation, neurodegeneration, and brain trauma
EP4007818A4 (en) METHODS AND REAGENTS FOR NUCLEIC ACID SEQUENCING AND RELATED APPLICATIONS
GB2613427B (en) Methods and Systems for Analyzing Nucleic Acid Molecules
EP3775259A4 (en) NUCLEIC ACID MOLECULES SEQUENCING PROCESSES
WO2016109799A3 (en) Method of rna isolation from clinical samples
EP3621607A4 (en) METHOD AND SYSTEMS FOR PULLING DNA, RNA AND OTHER BIOLOGICAL MOLECULES THROUGH NANOPORES USING SOFT MAGNETIC STRUCTURES
EP3773609A4 (en) DOUBLE-STRANDED NUCLEIC ACID INHIBITOR MOLECULES MODIFIED WITH Tm-INCREASING NUCLEOTIDES
EP3963106A4 (en) METHODS FOR SEQUENCING NUCLEIC ACID MOLECULES
SG11202111077RA (en) Double-stranded nucleic acid inhibitor molecules with shortened sense strands
IT202200006119A1 (it) Method for implementing the design of synthetic nucleic acid molecules for gene therapies in rare diseases.